Clinical Trial Update: Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway [Phase 3]

View source ↗

Summary

Phase 3 trial comparing wound infiltration with liposomal bupivacaine versus standard bupivacaine in open gynecologic surgery on an enhanced recovery pathway; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer
• Malignant Neoplasms of Female Genital Organs

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasms of Female Genital Organs, Gynecologic Cancer | Phase 3 | Status: TERMINATED | Results posted: 2021-09-22